CN110236710A - A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting - Google Patents
A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting Download PDFInfo
- Publication number
- CN110236710A CN110236710A CN201810198795.XA CN201810198795A CN110236710A CN 110236710 A CN110236710 A CN 110236710A CN 201810198795 A CN201810198795 A CN 201810198795A CN 110236710 A CN110236710 A CN 110236710A
- Authority
- CN
- China
- Prior art keywords
- bone
- maxillary sinus
- grafting material
- promoting
- skeletonization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004086 maxillary sinus Anatomy 0.000 title claims abstract description 67
- 239000000463 material Substances 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 31
- 230000001737 promoting effect Effects 0.000 title claims abstract description 19
- 210000000988 bone and bone Anatomy 0.000 title abstract description 75
- 230000011164 ossification Effects 0.000 title abstract description 15
- 239000004053 dental implant Substances 0.000 title description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 45
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 45
- 239000001301 oxygen Substances 0.000 claims abstract description 45
- 230000008569 process Effects 0.000 claims description 8
- 230000002980 postoperative effect Effects 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000282326 Felis catus Species 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 230000003252 repetitive effect Effects 0.000 claims 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims 1
- 241000009328 Perro Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 230000000630 rising effect Effects 0.000 claims 1
- 230000035876 healing Effects 0.000 abstract description 18
- 239000007943 implant Substances 0.000 abstract description 18
- 238000011084 recovery Methods 0.000 abstract description 5
- 230000006641 stabilisation Effects 0.000 abstract description 5
- 238000011105 stabilization Methods 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000002513 implantation Methods 0.000 abstract description 2
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 13
- 210000004877 mucosa Anatomy 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 4
- 102000004067 Osteocalcin Human genes 0.000 description 4
- 108090000573 Osteocalcin Proteins 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 210000002050 maxilla Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 3
- 102000008143 Bone Morphogenetic Protein 2 Human genes 0.000 description 3
- 102000015775 Core Binding Factor Alpha 1 Subunit Human genes 0.000 description 3
- 108010024682 Core Binding Factor Alpha 1 Subunit Proteins 0.000 description 3
- 208000006735 Periostitis Diseases 0.000 description 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 210000003460 periosteum Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000316 bone substitute Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 102100025368 Runt-related transcription factor 2 Human genes 0.000 description 1
- 101710102802 Runt-related transcription factor 2 Proteins 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010048031 Wound dehiscence Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229960002152 chlorhexidine acetate Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000007408 cone-beam computed tomography Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/06—Implements for therapeutic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0089—Implanting tools or instruments
- A61C8/0092—Implanting tools or instruments for sinus lifting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0093—Features of implants not otherwise provided for
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Otolaryngology (AREA)
- Dental Prosthetics (AREA)
Abstract
本发明涉及一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,属于医疗领域。一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,包括下述步骤:S1,使上颌窦内置入植骨材料的载体处于高压氧设备中;S2,高压氧设备按下述参数运行:含氧量100%、供氧时间2小时、压力值2ATA、升压时间为30分钟、稳压时间为60分钟、降压时间为30分钟;S3,使上颌窦内置入植骨材料的载体离开高压氧设备;S4,每20‑30小时重复步骤S1至步骤S3一次,共重复30‑60次。本发明的有益效果是使常规上颌窦内植骨愈合时间从8‑9个月缩减到5‑9周,便于患者早期牙槽骨种植床的愈合和功能恢复。
The invention relates to a method for promoting osteogenesis of a bone graft material after lifting outside the maxillary sinus, and belongs to the medical field. A method for promoting bone formation of bone graft material after maxillary sinus lifting after implantation, comprising the following steps: S1, placing the carrier of bone graft material in the maxillary sinus in hyperbaric oxygen equipment; S2, pressing down the hyperbaric oxygen equipment The operation of the above parameters: oxygen content 100%, oxygen supply time 2 hours, pressure value 2ATA, pressure increase time 30 minutes, pressure stabilization time 60 minutes, pressure reduction time 30 minutes; The material carrier leaves the hyperbaric oxygen equipment; S4, repeat steps S1 to S3 every 20-30 hours, and repeat 30-60 times in total. The beneficial effect of the invention is that the healing time of the conventional maxillary sinus bone graft is shortened from 8-9 months to 5-9 weeks, which facilitates the healing and functional recovery of the early alveolar bone implant bed of patients.
Description
技术领域technical field
本发明涉及一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,属于医疗领域。The invention relates to a method for promoting bone formation of a bone graft material after lifting outside the maxillary sinus, and belongs to the medical field.
背景技术Background technique
口腔种植牙技术已经成为逐步替代传统牙列缺损和牙列缺失患者的修复方式。临床中,当患者上颌后牙区缺失牙时,由于上颌窦的存在、上颌窦窦底的牙槽骨拔牙后继发的颌骨骨改建和上颌窦本身气化等原因,使上颌后牙受植区的骨高度下降,在植入理想长度的种植体时可能造成上颌窦粘膜穿孔,导致继发感染失败,这在一定程度上限制了合理种植体长度的选择和临床应用。为了植入理想长度种植体并达到合理的生物力学要求,常需要将患者上颌窦窦底粘膜提升到理想的高度,这种手术称为上颌窦提升术。根据患者上颌窦底基骨的条件,将手术分为上颌窦内提升和外提升手术两种。后者能够解决上颌后牙区基骨的骨量不足的普遍问题,在临床中得到常规使用。Dental implant technology has gradually replaced traditional dentition defects and edentulous patients. In clinical practice, when a patient loses teeth in the maxillary posterior region, the maxillary posterior teeth are implanted due to the existence of the maxillary sinus, the remodeling of the maxillary bone after extraction of the alveolar bone at the maxillary sinus floor, and the gasification of the maxillary sinus itself. The bone height in the area decreases, which may cause perforation of the maxillary sinus mucosa when an implant of ideal length is placed, resulting in failure of secondary infection, which limits the selection and clinical application of a reasonable implant length to a certain extent. In order to place implants of ideal length and meet reasonable biomechanical requirements, it is often necessary to elevate the maxillary sinus floor mucosa to an ideal height. This operation is called maxillary sinus lift. According to the condition of the maxillary sinus base bone, the operation can be divided into two types: internal lifting and external lifting of the maxillary sinus. The latter can solve the general problem of insufficient bone mass in the maxillary posterior region, and is routinely used in clinic.
在上颌窦外提升手术过程中,将上颌窦粘膜从窦底剥离后抬高,在上颌窦底和被抬起的上颌窦粘膜之间放置自体骨骨或骨代用品,以增加上颌后部牙槽嵴顶到窦底的高度,这是解决上颌骨后部骨量不足的有效方法,并为后期牙种植体成功行使功能提供保证,最终使植骨能够完全与种植体发生可靠的骨整合,支撑种植体上部的修复体。适宜的骨移植材料和成骨性能直接影响到上颌窦底提升术后牙种植的临床效果,因此探讨上颌窦底提升术中理想的植骨材料是国内外学者近年来研究的热点。During maxillary sinus lifting surgery, the maxillary sinus mucosa is lifted from the sinus floor, and autogenous bone or bone substitute is placed between the maxillary sinus floor and the raised maxillary sinus mucosa to increase the maxillary posterior teeth. The height from the top of the trough to the bottom of the sinus is an effective method to solve the lack of bone in the posterior part of the maxilla, and it provides a guarantee for the successful functioning of the dental implant in the later stage, and finally enables the bone graft to completely and reliably osseointegrate with the implant. Supports the restoration above the implant. Appropriate bone graft material and osteogenic performance directly affect the clinical effect of dental implants after maxillary sinus floor lifting.
现在普遍认为,自体骨移植被认为是骨移植的最佳选择,但为了避免由于取材于自体骨致使患者口内外被开辟第二术区而继发的术后疼痛、肿胀、感染和神经麻木等术后并发症,学者们一直在寻求能够替代自体骨的移植材料。同种异体骨、异种骨及各类陶瓷材料、聚合物都先后被作为骨替代品用于上颌窦底提升术中。目前,标准的上颌窦外提升术式结合Bio-Oss植骨是解决上颌后牙区巨大上颌窦导致的种植骨量不足的唯一方法。Bio-Oss是经过去除蛋白及其他有机成份的衍生骨,作为成骨细胞爬行支架,Bio-Oss的结构与人体骨的结构几乎相同,生物相容性好,具有优良的骨引导功能。然而,由于Bio-Oss缺乏骨诱导性能,患者需要等待常规骨愈合期为8-9个月,才能形成比较可靠的种植牙牙槽骨床,组织学检查结果显示新骨生成良好,并且随时间延长,骨的结构逐步形成并成熟,在此之后才能负重或进行植体的埋入。由于成骨时间过长,严重限制了这类颌骨条件下患者种植牙功能的早期恢复,迫切要求临床医生追求更新的生物材料和方法来缩短骨愈合期,提升愈合效果和能力。It is now generally believed that autologous bone grafting is considered the best choice for bone grafting, but in order to avoid postoperative pain, swelling, infection, and nerve numbness caused by opening a second surgical area inside and outside the patient's mouth due to the use of autologous bone Scholars have been looking for graft materials that can replace autologous bone due to postoperative complications. Allograft bone, xenograft bone, various ceramic materials, and polymers have been successively used as bone substitutes in maxillary sinus floor lifting. At present, the standard external maxillary sinus lift combined with Bio-Oss bone grafting is the only way to solve the insufficient amount of bone implants caused by the huge maxillary sinus in the posterior maxillary region. Bio-Oss is derived bone that has removed protein and other organic components. As a scaffold for osteoblasts, the structure of Bio-Oss is almost the same as that of human bone. It has good biocompatibility and excellent bone conduction function. However, due to the lack of osteoinductive properties of Bio-Oss, patients need to wait for the conventional bone healing period of 8-9 months to form a relatively reliable alveolar bone bed for implants. Histological examination results show that new bone formation is good and prolongs over time , the bone structure gradually forms and matures, after which weight bearing or implant placement can be carried out. Due to the long bone formation time, the early restoration of dental implant function in patients with such jaw conditions is severely limited, and clinicians are urgently required to pursue newer biomaterials and methods to shorten the bone healing period and improve the healing effect and ability.
发明内容Contents of the invention
本发明主要是为找到快速促进Bio-Oss植骨在上颌窦外提升后的成骨效果的有效方法,解决目前愈合时间过长,功能恢复过久的瓶颈问题。The main purpose of the present invention is to find an effective method to quickly promote the osteogenesis effect of Bio-Oss bone graft outside the maxillary sinus, and solve the current bottleneck problems of too long healing time and too long functional recovery.
为实现上述目的,本发明采用以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,包括下述步骤:A method for promoting osteogenesis of a bone graft material after a maxillary sinus is lifted outside the dental implant, comprising the following steps:
S1,使上颌窦内置入植骨材料的载体处于高压氧设备中;S1, placing the carrier of the bone graft material in the maxillary sinus in the hyperbaric oxygen device;
S2,高压氧设备按下述参数运行:含氧量100%、供氧时间2小时、压力值2ATA、升压时间为30分钟、稳压时间为60分钟、降压时间为30分钟;S2, the hyperbaric oxygen equipment operates according to the following parameters: oxygen content 100%, oxygen supply time 2 hours, pressure value 2ATA, boost time 30 minutes, pressure stabilization time 60 minutes, depressurization time 30 minutes;
S3,使上颌窦内置入植骨材料的载体离开高压氧设备;S3, leaving the carrier of the bone graft material in the maxillary sinus away from the hyperbaric oxygen device;
S4,每20-30小时重复步骤S1至步骤S3一次,共重复30-60次。S4, repeat step S1 to step S3 once every 20-30 hours, and repeat 30-60 times in total.
所述步骤S4还包括,当重复步骤S1至步骤S3达到20次时,中止100-140小时,之后再开始新的一轮步骤S1至步骤S3的重复过程。The step S4 also includes, when repeating steps S1 to S3 reaches 20 times, suspending for 100-140 hours, and then starting a new round of repeating process of steps S1 to S3.
所述步骤S4,优选每24小时重复步骤S1至步骤S3一次,共重复30-54次。The step S4 is preferably repeated from step S1 to step S3 once every 24 hours, for a total of 30-54 times.
所述步骤S4,优选当重复步骤S1至步骤S3达到20次时,中止120小时,之后再开始新的一轮步骤S1至步骤S3的重复过程。The step S4 is preferably stopped for 120 hours when repeating steps S1 to S3 reaches 20 times, and then starts a new round of repeating process of steps S1 to S3.
所述植骨材料为Bio-Oss。Bio-Oss骨粉由瑞士盖氏制药有限公司生产,商品名为Geistlich Bio- The bone graft material is Bio-Oss. Bio-Oss bone powder is produced by Geistlich Pharmaceutical Co., Ltd. in Switzerland, and its trade name is Geistlich Bio-
所述载体为哺乳动物,包括动物和人。所述动物为鼠、兔、猫、犬、猪等。The carrier is a mammal, including animals and humans. The animals are mice, rabbits, cats, dogs, pigs and the like.
通过高压氧舱作用于上颌窦外提升术后患者,通过控制氧舱的氧气浓度和压力,经过升压、稳压和降压时间和速度控制,以及实施高压氧疗的时机和频次,发明快速促进Bio-Oss植骨在上颌窦外提升后的成骨效果的有效方法,解决目前愈合时间过长,患者功能恢复过久的瓶颈问题。The hyperbaric oxygen chamber acts on the patients after maxillary sinus lifting, by controlling the oxygen concentration and pressure of the oxygen chamber, controlling the time and speed of boosting, stabilizing and lowering the pressure, and the timing and frequency of hyperbaric oxygen therapy. It is an effective method to promote the osteogenesis effect of Bio-Oss bone graft after maxillary sinus lifting, and solve the current bottleneck problem of too long healing time and too long functional recovery of patients.
本发明中高压氧的早期应用同样适用于上颌窦内提升植骨术和口腔颌骨缺损的相关的骨再生愈合手术,同样能够促进骨愈合的早期实现。各种生长因子和植骨材料同样适用于该高压氧作用的时间窗。The early application of hyperbaric oxygen in the present invention is also applicable to bone grafting in the maxillary sinus and related bone regeneration and healing operations for oral and maxillary defects, and can also promote the early realization of bone healing. Various growth factors and bone graft materials are also suitable for this time window of hyperbaric oxygen action.
传统的上颌窦外提升术,Bio-Oss植骨后需要至少8-9个月的自然愈合时间。目前研究证实:增加氧浓度,有助于BMSC的存活及其向成骨细胞分化,可以增强成骨细胞、破骨细胞、成纤维细胞和内皮细胞的增殖与分裂,加速肉芽组织和纤维组织增生,并可加速钙的吸收,从而加速骨质的形成和成熟。在骨折早期,高压氧的血管收缩效应可使局部组织血流量减少,血管通透性降低,水肿消除。此外,高压氧还有加速骨折和软组织损伤部位毛细血管新生和促进侧枝循环建立的作用。由于血液供应和氧供应的增加,改善了局部营养供应,骨痂迅速生长,从而促进骨折愈合。本方法充分利用高压氧在肢体骨折上的可靠证据,将高压氧疗方法早期应用到口腔上颌窦外提升结合Bio-Oss植骨术后,一方面能够极大地减少因为颜面部血流丰富所容易导致的术后肿胀和伤口裂开,另一方面通过高压氧疗压力和作用时间以及频次的控制,通过组织形态学分析证实,高压氧能够达到早期促进上颌窦内异种异体成骨的效果,组织学上成骨的愈合状态的相似度从8-9个月提前到5-9周。便于患者早期牙槽骨种植床的愈合和功能恢复。应用高压氧辅助Bio-Oss用于上颌窦外提升成骨的有效作用时间窗的研究,目前国际上是个空白。For traditional maxillary sinus augmentation, Bio-Oss bone graft requires at least 8-9 months of natural healing time. Current studies have confirmed that increasing the oxygen concentration is conducive to the survival of BMSCs and their differentiation into osteoblasts, can enhance the proliferation and division of osteoblasts, osteoclasts, fibroblasts and endothelial cells, and accelerate the proliferation of granulation tissue and fibrous tissue , and can accelerate the absorption of calcium, thereby accelerating the formation and maturation of bone. In the early stage of fracture, the vasoconstriction effect of hyperbaric oxygen can reduce blood flow in local tissues, reduce vascular permeability, and eliminate edema. In addition, hyperbaric oxygen can also accelerate the formation of capillaries at the site of fracture and soft tissue injury and promote the establishment of collateral circulation. Due to the increased blood supply and oxygen supply, the local nutrient supply is improved, and the callus grows rapidly, thereby promoting fracture healing. This method makes full use of the reliable evidence of hyperbaric oxygen therapy on limb fractures, and applies hyperbaric oxygen therapy to the oral and maxillary sinus lifting combined with Bio-Oss bone grafting. Postoperative swelling and wound dehiscence, on the other hand, through the control of hyperbaric oxygen therapy pressure, action time and frequency, and histomorphological analysis, hyperbaric oxygen can achieve the effect of early promoting xenograft bone formation in the maxillary sinus. The similarity of osteogenic healing state was advanced from 8-9 months to 5-9 weeks. It is convenient for the healing and functional recovery of the early alveolar bone implant bed of patients. The research on the effective time window of the application of hyperbaric oxygen-assisted Bio-Oss in maxillary sinus lifting osteogenesis is currently a blank in the world.
与传统的上颌窦外提升成骨技术相比,本发明的有益效果是使常规上颌窦内植骨愈合时间从8-9个月缩减到5-9周,便于患者早期牙槽骨种植床的愈合和功能恢复。Compared with the traditional maxillary sinus external lifting osteogenesis technology, the beneficial effect of the present invention is that the healing time of the conventional maxillary sinus bone graft is shortened from 8-9 months to 5-9 weeks, which is convenient for the early alveolar bone implantation bed of patients. Healing and functional recovery.
下面结合附图和具体实施方式对本发明做进一步说明,并非对本发明的限定,凡依照本发明公开内容所进行的本领域等同替换,均属于本发明的保护范围。The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, which are not intended to limit the present invention. All equivalent replacements in the field performed according to the disclosed content of the present invention belong to the protection scope of the present invention.
附图说明Description of drawings
图1为上颌窦外提升和Bio-Oss植骨手术Figure 1 shows maxillary sinus lift and Bio-Oss bone grafting
图2A和图2B为高压氧疗后组织块标本取出Figure 2A and Figure 2B are tissue block specimens taken out after hyperbaric oxygen therapy
图3为种植体植入Figure 3 shows implant placement
图4为BMP-2(骨形态发生蛋白-2)在结缔组织中阳性表达Figure 4 shows the positive expression of BMP-2 (bone morphogenetic protein-2) in connective tissue
图5为VEGF(血管内皮生长因子)在结缔组织中阳性表达Figure 5 shows the positive expression of VEGF (vascular endothelial growth factor) in connective tissue
图6为Runx2(Runt相关转录因子2)的阳性表达Figure 6 shows the positive expression of Runx2 (Runt-related transcription factor 2)
图7为Osteocalcin(骨钙素)在新生骨组织里面阳性表达Figure 7 shows the positive expression of Osteocalcin (Osteocalcin) in new bone tissue
具体实施方式Detailed ways
实施例1Example 1
一.试验对象1. Test object
本实施例中的患者存在上颌后牙区缺失牙情况。由于上颌骨内的上颌窦的存在,该缺牙区由于种植牙的预备牙槽骨床不够高,需要在上颌窦的外侧壁骨壁开窗(图1),将Bio-OSS骨粉植入,骨窗用Bio-Guide覆盖。分为空白组、实验组和对照组。The patient in this example has missing teeth in the maxillary posterior region. Due to the existence of the maxillary sinus in the maxilla, the prepared alveolar bone bed for the implant is not high enough in this edentulous area, so it is necessary to open a window on the outer wall of the maxillary sinus (Figure 1), and implant Bio-OSS bone powder. The bone window was covered with Bio-Guide. Divided into blank group, experimental group and control group.
实验组:T1组(6周节点的亚组),术后进行6周高压氧治疗Experimental group: T1 group (subgroup of 6-week node), after 6 weeks of hyperbaric oxygen therapy
T2组(9周节点的亚组),术后进行9周高压氧治疗T2 group (subgroup of 9-week node), 9 weeks of hyperbaric oxygen therapy after surgery
T3组(5周节点的亚组),术后进行5周高压氧治疗T3 group (subgroup of 5-week node), 5 weeks of hyperbaric oxygen therapy after surgery
对照组:术后采用传统方式自然愈合的患者Control group: patients who healed naturally with traditional methods after surgery
二、试验方法2. Test method
1.上颌窦外提升手术:术区碧蓝麻局部浸入麻醉,采用15C手术刀片于上颌后牙缺牙区牙槽嵴顶偏腭侧切口,直达骨膜。近远中邻牙牙龈沟内切口,依据缺失牙的数量和上颌窦外提升开窗的大小,近远中各延伸一个牙位,近中做垂直切口过膜龈联合;远中为游离端时,做颊侧短垂直切口,梯形全厚瓣翻开暴露上颌窦外侧骨壁。根据术前CBCT(牙科锥体术CT),使用超声骨刀进行骨壁开窗。开窗下界水平线切口位于上颌窦底基骨之上2-3毫米处,根据上颌窦底基骨高度和种植体的长度加2mm的原则作为骨壁开窗上界水平向切口,近远中开窗截骨线根据植骨范围决定。暴露上颌窦粘膜,骨膜剥离子小心进行窦底粘膜向上向内的剥离,Bio-OSS小颗粒骨粉填塞,洞壁外Bio-Guide骨膜覆盖骨壁开窗,粘骨膜全厚瓣无张力对位缝合。1. Extramaxillary sinus lifting surgery: local incandescent anesthesia was used in the operation area, and a 15C surgical blade was used to make an incision on the palatal side of the alveolar crest in the edentulous area of the maxillary posterior, reaching the periosteum. The incision is made in the gingival sulcus of the adjacent teeth in the mesiodistal area. According to the number of missing teeth and the size of the maxillary sinus lift window, one tooth position is extended in the mesiodistal area, and a vertical incision is made in the mesial area across the gingival symphysis; when the distal end is the free end A short vertical incision was made on the buccal side, and the trapezoidal full-thickness flap was opened to expose the lateral bone wall of the maxillary sinus. Bone wall fenestration was performed using an ultrasonic osteotome according to preoperative CBCT (dental cone surgery CT). The horizontal incision at the lower limit of the fenestration is located 2-3 mm above the base of the maxillary sinus. According to the principle of adding 2 mm to the height of the base of the maxillary sinus and the length of the implant, it is used as the horizontal incision at the upper limit of the bone wall fenestration. The window osteotomy line is determined according to the extent of bone grafting. The maxillary sinus mucosa was exposed, the periosteum peeled off the sinus floor mucosa upwards and inwards carefully, Bio-OSS small particle bone meal was packed, the Bio-Guide periosteum outside the hole wall covered the bone wall and the window was opened, and the full-thickness mucoperiosteal flap was sutured without tension .
2.上颌窦外提升术后常规医嘱:口服非甾体抗炎药一周,24小时后醋酸氯已定含漱口,局部冷敷48小时;避免游泳、擤鼻涕和感冒;注意休息。2. Routine doctor's advice after maxillary sinus lifting: take non-steroidal anti-inflammatory drugs orally for one week, rinse mouth with chlorhexidine acetate 24 hours later, and apply local cold compresses for 48 hours; avoid swimming, blowing your nose and catching a cold; pay attention to rest.
3.高压氧辅助治疗3. Adjuvant hyperbaric oxygen therapy
上颌窦外提升术后24小时,开始进行常规的高压氧治疗。患者进入高压氧舱前由医生排除高压氧治疗的禁忌症。氧舱技术参数设置如下:压力2ATA下100%氧气,治疗的前30分钟升压,保压(稳压)60分钟,治疗的后30分钟降压,共计120分钟高压氧(HBO)作用,每天(24小时)一次,10天为一个疗程。24 hours after maxillary sinus lift, routine hyperbaric oxygen therapy was started. Before the patients entered the hyperbaric oxygen chamber, doctors ruled out the contraindications of hyperbaric oxygen therapy. The technical parameters of the oxygen chamber are set as follows: 100% oxygen at a pressure of 2 ATA, the pressure is increased for the first 30 minutes of treatment, the pressure is kept (stabilized) for 60 minutes, and the pressure is lowered for the last 30 minutes of treatment. (24 hours) once, 10 days as a course of treatment.
(1)5周节点的亚组(T3组),HBO持续两个疗程治疗共20天,停止5天,再进行10天高压氧治疗结束;(1) For the subgroup at the 5-week node (T3 group), HBO continued for two courses of treatment for a total of 20 days, stopped for 5 days, and then ended with 10 days of hyperbaric oxygen therapy;
(2)6周节点的亚组(T1组):HBO持续两个疗程20天,停止5天,再持续17天HBO治疗停止;(2) The subgroup at the 6-week node (T1 group): HBO treatment continued for two courses for 20 days, stopped for 5 days, and continued for 17 days to stop HBO treatment;
(3)9周节点的亚组(T2组):HBO持续两个疗程20天,停止5天,再持续HBO治疗20天,停止5天,再持续14天。(3) Subgroup at the 9-week node (T2 group): HBO treatment continued for two courses for 20 days, stopped for 5 days, continued HBO treatment for 20 days, stopped for 5 days, and continued for 14 days.
三、实验结果3. Experimental results
本实施例中的患者为上颌后牙区缺失牙情况。由于上颌骨内的上颌窦的存在,该缺牙区由于种植牙的预备牙槽骨床不够高,需要在上颌窦的外侧壁骨壁开窗(图1),将Bio-OSS骨粉植入,骨窗用Bio-Guide覆盖,等待骨自然愈合8-9个月后,种植体植入负重,进行功能修复(图3)。图2A和图2B为高压氧疗后,在制取骨标本组织块的同时,进行种植床的预备。The patient in this embodiment is the situation of missing teeth in the maxillary posterior region. Due to the existence of the maxillary sinus in the maxilla, the prepared alveolar bone bed for the implant is not high enough in this edentulous area, so it is necessary to open a window on the outer wall of the maxillary sinus (Figure 1), and implant Bio-OSS bone powder. The bone window was covered with Bio-Guide, and after 8-9 months of natural bone healing, the implants were placed under load for functional restoration (Fig. 3). Figure 2A and Figure 2B show the preparation of the implant bed while the bone specimen tissue block was being prepared after hyperbaric oxygen therapy.
实验结束后,从治疗部位取骨骼样本进行形态学和生化指标的检测,结果如图4至图7所示。After the experiment, bone samples were taken from the treatment site for detection of morphological and biochemical indicators, and the results are shown in Figures 4 to 7.
图4为BMP-2 200-fold结缔组织中阳性表达图。图4A为Ctl六周,48y;图4B为Treated1(T1组)六周,72y;图4C为Treated2(T2组),九周,62y;图4D为Treated3(T3组)五周,32y;图4E为Traditional(对照组)13Mons,60y;图4F为各组BMP2值。Figure 4 is a graph showing the positive expression of BMP-2 in 200-fold connective tissue. Fig. 4A is Ctl six weeks, 48y; Fig. 4B is Treated1 (T1 group) six weeks, 72y; Fig. 4C is Treated2 (T2 group), nine weeks, 62y; Fig. 4D is Treated3 (T3 group) five weeks, 32y; Fig. 4E is Traditional (control group) 13Mons, 60y; Figure 4F is the BMP2 value of each group.
图5为VEGF100X结缔组织中阳性区域。图5A为Ctl六周,48y;图5B为Treated1(T1组)六周,72y;图5C为Treated2(T2组),九周,62y;图5D为Treated3(T3组)五周,32y;图5E为Traditional(对照组)13Mons,60y;图5F为各组VEGF值。Figure 5 is the positive area of VEGF100X connective tissue. Fig. 5A is Ctl six weeks, 48y; Fig. 5B is Treated1 (T1 group) six weeks, 72y; Fig. 5C is Treated2 (T2 group), nine weeks, 62y; Fig. 5D is Treated3 (T3 group) five weeks, 32y; Fig. 5E is Traditional (control group) 13Mons, 60y; Figure 5F is the VEGF value of each group.
图6为Runx2 200X图,在细胞核中更多些,阳性区域是图中染成棕色的细胞。图6A为Ctl六周,48y;图6B为Treated1(T1组)六周,72y;图6C为Treated2(T2组),九周,62y;图6D为Treated3(T3组)五周,32y;图6E为Traditional(对照组)13Mons,60y;图6F为各组Runx2值。Figure 6 is a 200X image of Runx2, more in the nucleus, and the positive area is the cells stained brown in the image. Fig. 6A is Ctl six weeks, 48y; Fig. 6B is Treated1 (T1 group) six weeks, 72y; Fig. 6C is Treated2 (T2 group), nine weeks, 62y; Fig. 6D is Treated3 (T3 group) five weeks, 32y; Fig. 6E is Traditional (control group) 13Mons, 60y; Figure 6F is the Runx2 value of each group.
图6为Osteocalcin 100X新生骨组织里边阳性表达图。图7A为Ctl六周,48y;图7B为Treated1(T1组)六周,72y;图7C为Treated2(T2组),九周,62y;图7D为Treated3(T3组)五周,32y;图7E为Traditional(对照组)13Mons,60y;图7F为各组Osteocalcin值。Figure 6 is a positive expression map of Osteocalcin 100X in new bone tissue. Fig. 7A is Ctl six weeks, 48y; Fig. 7B is Treated1 (T1 group) six weeks, 72y; Fig. 7C is Treated2 (T2 group), nine weeks, 62y; Fig. 7D is Treated3 (T3 group) five weeks, 32y; Fig. 7E is Traditional (control group) 13Mons, 60y; Figure 7F is the value of Osteocalcin in each group.
结果显示出,根据患者年龄和个体代谢的差异,上颌窦外提升植骨后24小时,早期高压氧作用5-9周这个时间窗具有明显的促进骨愈合的作用。便于种植牙牙槽骨床的早期愈合。The results showed that, according to the differences in patient age and individual metabolism, 24 hours after maxillary sinus lifting and bone grafting, the time window of early hyperbaric oxygen for 5-9 weeks had a significant effect on promoting bone healing. Facilitate the early healing of the implanted alveolar bone bed.
实施例2Example 2
一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,包括下述步骤:A method for promoting osteogenesis of a bone graft material after a maxillary sinus is lifted outside the dental implant, comprising the following steps:
S1,使上颌窦内置入植骨材料Bio-Oss的载体处于高压氧设备中;S1, placing the carrier of the bone graft material Bio-Oss in the maxillary sinus in the hyperbaric oxygen equipment;
S2,高压氧设备按下述参数运行:含氧量100%、供氧时间2小时、压力值2ATA、升压时间为30分钟、稳压时间为60分钟、降压时间为30分钟;S2, the hyperbaric oxygen equipment operates according to the following parameters: oxygen content 100%, oxygen supply time 2 hours, pressure value 2ATA, boost time 30 minutes, pressure stabilization time 60 minutes, depressurization time 30 minutes;
S3,使上颌窦内置入植骨材料的载体离开高压氧设备;S3, leaving the carrier of the bone graft material in the maxillary sinus away from the hyperbaric oxygen device;
S4,每24小时重复步骤S1至步骤S3一次,共重复30次,第20次后中止120小时,之后再开始新的一轮步骤S1至步骤S3的重复过程。S4, repeat step S1 to step S3 once every 24 hours, repeat 30 times in total, stop for 120 hours after the 20th time, and then start a new round of repeating process from step S1 to step S3.
所述载体为人。The carrier is human.
实施例3Example 3
一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,包括下述步骤:A method for promoting osteogenesis of a bone graft material after a maxillary sinus is lifted outside the dental implant, comprising the following steps:
S1,使上颌窦内置入植骨材料Bio-Oss的载体处于高压氧设备中;S1, placing the carrier of the bone graft material Bio-Oss in the maxillary sinus in the hyperbaric oxygen equipment;
S2,高压氧设备按下述参数运行:含氧量100%、供氧时间2小时、压力值2ATA、升压时间为30分钟、稳压时间为60分钟、降压时间为30分钟;S2, the hyperbaric oxygen equipment operates according to the following parameters: oxygen content 100%, oxygen supply time 2 hours, pressure value 2ATA, boost time 30 minutes, pressure stabilization time 60 minutes, depressurization time 30 minutes;
S3,使上颌窦内置入植骨材料的载体离开高压氧设备;S3, leaving the carrier of the bone graft material in the maxillary sinus away from the hyperbaric oxygen device;
S4,每24小时重复步骤S1至步骤S3一次,共重复54次:第一个20次后中止120小时,之后再重复步骤S1至步骤S3的过程20次,再中止120小时,之后再重复步骤S1至步骤S3的过程14次。S4, repeat step S1 to step S3 once every 24 hours, and repeat 54 times in total: stop for 120 hours after the first 20 times, then repeat the process of step S1 to step S3 for 20 times, stop for another 120 hours, and then repeat steps The process from S1 to step S3 is 14 times.
所述载体为人。The carrier is human.
实施例4Example 4
一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法,包括下述步骤:A method for promoting osteogenesis of a bone graft material after a maxillary sinus is lifted outside the dental implant, comprising the following steps:
S1,使上颌窦内置入植骨材料Bio-Oss的载体处于高压氧设备中;S1, placing the carrier of the bone graft material Bio-Oss in the maxillary sinus in the hyperbaric oxygen equipment;
S2,高压氧设备按下述参数运行:含氧量100%、供氧时间2小时、压力值2ATA、升压时间为30分钟、稳压时间为60分钟、降压时间为30分钟;S2, the hyperbaric oxygen equipment operates according to the following parameters: oxygen content 100%, oxygen supply time 2 hours, pressure value 2ATA, boost time 30 minutes, pressure stabilization time 60 minutes, depressurization time 30 minutes;
S3,使上颌窦内置入植骨材料的载体离开高压氧设备;S3, leaving the carrier of the bone graft material in the maxillary sinus away from the hyperbaric oxygen device;
S4,每24小时重复步骤S1至步骤S3一次,共重复37次,重复20次后中止120小时,之后再开始新的一轮步骤S1至步骤S3的重复过程,共17次。S4, repeat step S1 to step S3 once every 24 hours, 37 times in total, stop for 120 hours after repeating 20 times, and then start a new round of repeating process from step S1 to step S3, 17 times in total.
所述载体为人。The carrier is human.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810198795.XA CN110236710A (en) | 2018-03-09 | 2018-03-09 | A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810198795.XA CN110236710A (en) | 2018-03-09 | 2018-03-09 | A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110236710A true CN110236710A (en) | 2019-09-17 |
Family
ID=67882727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810198795.XA Pending CN110236710A (en) | 2018-03-09 | 2018-03-09 | A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110236710A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210154015A1 (en) * | 2019-11-27 | 2021-05-27 | Igor Roshkovan | Surgical Technique for alveolar ridge augmentation with maxillary sinus elevation (lateral approach) using a pre-portioned and ready pre-packaged graft composition in gelatin bag and method of producing it |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698328A (en) * | 1985-04-04 | 1987-10-06 | The General Hospital Corporation | Method of increasing bone mass |
| US6189537B1 (en) * | 1996-09-06 | 2001-02-20 | Lifenet | Process for producing osteoinductive bone, and osteoinductive bone produced thereby |
| CN1457821A (en) * | 2002-05-15 | 2003-11-26 | 孙进富 | Medicine for curing aseptic necrosis of head of femur |
| CN101020085A (en) * | 2007-02-14 | 2007-08-22 | 中国人民解放军总医院 | New-type of inorganic bone grafting material and its prepn and use |
| CN101370531A (en) * | 2005-11-17 | 2009-02-18 | 生物模拟治疗公司 | Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix |
| CN103622777A (en) * | 2005-05-04 | 2014-03-12 | 林正纶 | Wound protection and therapy system |
-
2018
- 2018-03-09 CN CN201810198795.XA patent/CN110236710A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698328A (en) * | 1985-04-04 | 1987-10-06 | The General Hospital Corporation | Method of increasing bone mass |
| US6189537B1 (en) * | 1996-09-06 | 2001-02-20 | Lifenet | Process for producing osteoinductive bone, and osteoinductive bone produced thereby |
| CN1457821A (en) * | 2002-05-15 | 2003-11-26 | 孙进富 | Medicine for curing aseptic necrosis of head of femur |
| CN103622777A (en) * | 2005-05-04 | 2014-03-12 | 林正纶 | Wound protection and therapy system |
| CN101370531A (en) * | 2005-11-17 | 2009-02-18 | 生物模拟治疗公司 | Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix |
| CN101020085A (en) * | 2007-02-14 | 2007-08-22 | 中国人民解放军总医院 | New-type of inorganic bone grafting material and its prepn and use |
Non-Patent Citations (1)
| Title |
|---|
| 蒋泽先等: "《现代牙科诊所指南》", 31 August 2006 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210154015A1 (en) * | 2019-11-27 | 2021-05-27 | Igor Roshkovan | Surgical Technique for alveolar ridge augmentation with maxillary sinus elevation (lateral approach) using a pre-portioned and ready pre-packaged graft composition in gelatin bag and method of producing it |
| US12419752B2 (en) * | 2019-11-27 | 2025-09-23 | Igor Roshkovan | Surgical technique for alveolar ridge augmentation with maxillary sinus elevation (lateral approach) using a pre-portioned and ready pre-packaged bone graft composition in gelatin bag and method of producing it |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oda et al. | Alveolar ridge augmentation by distraction osteogenesis using titanium implants: an experimental study | |
| Cortese et al. | Platelet-rich fibrin (PRF) in implant dentistry in combination with new bone regenerative technique in elderly patients | |
| Roccuzzo et al. | The importance of soft tissue condition in bone regenerative procedures to ensure long‐term peri‐implant health | |
| Hao et al. | Effect of umbilical cord mesenchymal stem cell in peri-implant bone defect after immediate implant: an experiment study in beagle dogs | |
| CN208193177U (en) | The protection structure of Alveolar Bone Defect bone graft area | |
| Sakka et al. | Simultaneous maxillary sinus lifting and implant placement with autogenous parietal bone graft: outcome of 17 cases | |
| Xu et al. | Periodontally accelerated osteogenic orthodontics with platelet-rich fibrin in an adult patient with periodontal disease: A case report and review of literature | |
| Mitrea et al. | The Sinus Lift Procedure Applied in Cases Where the Thickness of the Alveolar Bone Is Insufficient Using Double Prf as Well as in the Case of an Intrasinus Mucocele | |
| RU2375005C1 (en) | Method of plasty of perforation of maxillary sinus mucous tunic in case of sinus-lifting and implantation | |
| CN110236710A (en) | A method for promoting bone formation of bone graft material after dental implant maxillary sinus lifting | |
| Emilov et al. | Surgical treatment of gingival recession with soft tissue graft procedure | |
| Ivanova et al. | Clinical comparison of three methods for vestibuloplasty in the anterior part of the mandibule | |
| Zhang et al. | Improvement of implant placement after bone augmentation of severely resorbed maxillary sinuses with ‘tent-pole’grafting technique in combination with rhBMP-2 | |
| Thalmair et al. | The healing of free gingival autografts for socket-seal surgery: a case report | |
| Sleman et al. | Autogenous bone ring augmentation and simultaneous implant placement in the atrophic posterior maxilla: A case report | |
| Lenssen et al. | Immediate functional loading of provisional implants in the reconstructed atrophic maxilla: preliminary results of a prospective study after 6 months of loading with a provisional bridge | |
| MD595Z (en) | Method for early placement of dental implants in a single surgical technique | |
| RU2527840C2 (en) | Method for prevention of perforated maxillary sinus mucosa in sinus lifting surgery | |
| Biscaro et al. | A human histologic report of an implant placed with simultaneous sinus floor elevation without bone graft | |
| Krauser et al. | Implant site development: socket preservation | |
| RU2853657C1 (en) | Method for reconstruction of horizontal atrophy of alveolar bone | |
| Fontana et al. | Complications in guided bone regeneration | |
| RU2260391C2 (en) | Method for setting dental prostheses in lateral maxillary region | |
| Bezerra et al. | Immediate Implant Placement and Double Layer Socket Preservation Associated with Mix of Xenograft and Particulate Autogenous Bone Graft: A Case Report | |
| Fien et al. | Use of a sugar-crosslinked collagen membrane in conjunction with a dehydrated amnion/chorion membrane for guided bone regeneration around immediate implants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190917 |
|
| RJ01 | Rejection of invention patent application after publication |